Table 4.
Regression Model | Western pattern | cLVR | cLVH | eLVH | |||
---|---|---|---|---|---|---|---|
OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | ||
Model 1 | 1st tertile | Ref | Ref | Ref | |||
2nd tertile |
0.87 (0.1–1.45) |
0.599 |
3.04 (0.76–12.31) |
0.112 |
0.65 (0.20–2.00) |
0.437 | |
3rd tertile |
0.84 (0.48–1.43) |
0.512 |
3.70 (0.92–14.87) |
0.062 |
1.73 (0.65–4.69) |
0.300 | |
Trenda | 0.838 | 0.168 | 0.216 | ||||
Model 2 | 1st tertile | Ref | Ref | Ref | |||
2nd tertile |
0.94 (0.56–1.54) |
0.683 |
4.63 (0.95–20.65) |
0.057 |
0.71 (0.28–2.03) |
0.513 | |
3rd tertile |
0.93 (0.57–1.53) |
0.718 |
5.38 (1.17–23.58) |
0.035 |
1.45 (0.57–4.34) |
0.499 | |
Trenda | 0.912 | 0.041 | 0.387 |
ap-value for trend. Results are expressed as multivariable-adjusted odds ratio (OR) and 95% confidence interval (CI). Statistical analysis was performed using logistic regression adjusting for age, sex, BMI and waist circumference (Model 1), and further adjusting for physical activity (MET), smoking status, total energy intake, diabetes and hypertension (Model 2).
Abbreviations: concentric left ventricular remodelling, cLVR; concentric left ventricular hypertrophy, cLVH; eccentric left ventricular hypertrophy; reference group, Ref.